ACXP

Acurx Pharmaceuticals Inc

Stock NASDAQ – Stock Market Prices, News & Analysis

Acurx Pharmaceuticals specializes in the development of new antibiotics to treat bacterial infections.

$ 2.00
0.91 %

Acurx Pharmaceuticals Inc

$ 2.00
0.91 %
ACXP

Acurx Pharmaceuticals specializes in the development of new antibiotics to treat bacterial infections.

Price history of Acurx Pharmaceuticals Inc
Price history of Acurx Pharmaceuticals Inc

Performance & Momentum

6 Months 69.70 %
1 Year 76.13 %
3 Years 96.63 %
5 Years 98.73 %

Strategic Analysis

Acurx Pharmaceuticals Inc • 2026

Acurx Pharmaceuticals positions itself in the specialized niche of developing innovative antibiotics aimed at fighting resistant bacterial infections. Its strategy is based on cutting-edge medical research in a demanding pharmaceutical market, with a focus on therapeutic solutions addressing unmet medical needs.

Strengths
  • Targeted expertise in a high medical and societal value segment
  • Potential for therapeutic revolution in the face of increasing antibiotic resistance
Weaknesses
  • Lack of marketed products generating regular revenue
  • Long-term stock performance severely degraded, reflecting operational or clinical validation difficulties
Momentum

The current momentum is extremely low, marked by a prolonged decline in stock price that likely reflects significant obstacles in clinical development or funding. This dynamic suggests a high-risk profile, relegating investment to specialized investors willing to follow long-term projects.

Similar stocks to Acurx Pharmaceuticals Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone